J&J CEO sees Covid-19 shots in American arms in 1-2 days as shipping starts

J&J's vaccine requires only one shot, while other authorized vaccines require two.

Johnson
Vials of J&J vaccine
Reuters
2 min read Last Updated : Mar 01 2021 | 9:37 PM IST

By Susan Heavey

(Reuters) - Johnson & Johnson's newly authorized COVID-19 vaccine has started shipping and its top executive said on Monday that Americans should be able to receive the single-dose shot within the next 24 to 48 hours, adding a third vaccine in the United States.

The drugmaker plans to deliver 4 million vaccine doses this week, 20 million by the end of March and 100 million doses by June, J&J Chief Executive Office Alex Gorsky said in interviews with NBC News' Today program and CNBC.

"Within the next 24 to 28 hours, Americans should start receiving shots in arms. They're literally rolling out with the trucks as we speak," he said to NBC News.

J&J's vaccine requires only one shot, while other authorized vaccines require two.

"The faster we can get everybody vaccinated, the lower the chance for mutations and variants," Gorsky said in a CNBC interview.

The coronavirus has been circulating around the globe for more than a year and in recent months, new virus variants have arisen against which the J&J vaccine and others appear less effective. Public health officials say a global vaccination effort can help stem these variants from developing.

Gorsky said J&J was confident that its vaccine would have a "robust response" against these emerging variants, based on its clinical trial in countries including South Africa and Brazil where worrisome variants were circulating.

The company is developing a version of its vaccine to target the variant first found in South Africa, and will be ready to start late-stage trials by this summer.

Pfizer and German partner BioNTech and Moderna Inc have FDA-authorized two-dose vaccines.

Shares of J&J were up nearly 2% in premarket trading after the U.S. Food and Drug Administration gave it emergency use authorization on Saturday.

McKesson Corp said on Monday it had begun distributing the vaccine.

 

(Reporting by Susan Heavey in Washington and Manas Mishra in Bengaluru; Editing by Toby Chopra, Bernadette Baum and Maju Samuel)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Johnson and JohnsonCoronavirus VaccineHealth sector

First Published: Mar 01 2021 | 9:22 PM IST

Next Story